世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033965

医薬品研究製造受託(CRAM)の世界市場(2023-2027)

TechNavio

Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2023-2027

発刊日 2023/01/03

言語英語

体裁PDF/167ページ

ライセンス/価格167ページ

0000033965

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、医薬品研究製造受託(CRAM)市場を分析します。

世界の医薬品研究製造受託(CRAM)市場は、予測期間中に約10.32 %のCAGRで推移し、2022年から2027年の間に1,213億5,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、新興市場における費用対効果の高いリソースの利用可能性、コアコンピタンスに集中する必要性の高まり、強力な研究資金によって駆動されています。

調査範囲

  • 市場セグメント
    ➣ サービス別
      ◇ CMO
      ◇ CRO
    ➣ エンドユーザー別
      ◇ 大手医薬品
      ◇ 中小医薬品
      ◇ ジェネリック医薬品
    ➣ 地域別
      ◇ 北アメリカ
      ◇ アジア
      ◇ ヨーロッパ
      ◇ その他の地域

本調査では、今後数年間の医薬品研究製造受託(CRAM)市場の成長を牽引する主要な理由の一つとして、米国FDA認可の製造施設数の増加を挙げています。また、医薬品の特許切れの増加やビッグデータの出現は、市場の大きな需要につながるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 医薬品研究製造受託(CRAM)の市場規模
  • 医薬品研究製造受託(CRAM)の市場予測
  • 医薬品研究製造受託(CRAM)市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な医薬品研究製造受託(CRAM)市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Almac Group Ltd.
    ➣ Boehringer Ingelheim International GmbH
    ➣ Cadila Pharmaceuticals Ltd.
    ➣ Catalent Inc.
    ➣ Charles River Laboratories International Inc.
    ➣ Cmic Holdings Co. Ltd.
    ➣ Dr Reddys Laboratories Ltd.
    ➣ ICON plc
    ➣ IQVIA Holdings Inc.
    ➣ Laboratory Corp. of America Holdings
    ➣ Lonza Group Ltd.
    ➣ Lupin Ltd.
    ➣ Recipharm AB
    ➣ Samsung Electronics Co. Ltd.
    ➣ Syneos Health Inc.
    ➣ Thermo Fisher Scientific Inc.
    ➣ PCI Pharma Services
    ➣ Parexel International Corp.
    ➣ OPTIMAPHARM d.o.o.
    ➣ Novotech Australia Pty Ltd.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Service
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021 ($ billion)
4.2 Service Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Service Segment 2017 - 2021 ($ billion)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Service
6.1 Market segments
Exhibit 30: Chart on Service - Market share 2022-2027 (%)
Exhibit 31: Data Table on Service - Market share 2022-2027 (%)
6.2 Comparison by Service
Exhibit 32: Chart on Comparison by Service
Exhibit 33: Data Table on Comparison by Service
6.3 CMO - Market size and forecast 2022-2027
Exhibit 34: Chart on CMO - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on CMO - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on CMO - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on CMO - Year-over-year growth 2022-2027 (%)
6.4 CRO - Market size and forecast 2022-2027
Exhibit 38: Chart on CRO - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on CRO - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on CRO - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on CRO - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Service
Exhibit 42: Market opportunity by Service ($ billion)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 45: Chart on Comparison by End-user
Exhibit 46: Data Table on Comparison by End-user
7.3 Big pharmaceuticals - Market size and forecast 2022-2027
Exhibit 47: Chart on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Data Table on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Chart on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
7.4 Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027
Exhibit 51: Chart on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Data Table on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Chart on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
7.5 Generic pharmaceuticals - Market size and forecast 2022-2027
Exhibit 55: Chart on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 56: Data Table on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Chart on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 59: Market opportunity by End-user ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 India - Market size and forecast 2022-2027
Exhibit 85: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 87: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on India - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Almac Group Ltd.
Exhibit 108: Almac Group Ltd. - Overview
Exhibit 109: Almac Group Ltd. - Product / Service
Exhibit 110: Almac Group Ltd. - Key offerings
12.4 Boehringer Ingelheim International GmbH
Exhibit 111: Boehringer Ingelheim International GmbH - Overview
Exhibit 112: Boehringer Ingelheim International GmbH - Business segments
Exhibit 113: Boehringer Ingelheim International GmbH - Key news
Exhibit 114: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 115: Boehringer Ingelheim International GmbH - Segment focus
12.5 Cadila Pharmaceuticals Ltd.
Exhibit 116: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 117: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 118: Cadila Pharmaceuticals Ltd. - Key offerings
12.6 Catalent Inc.
Exhibit 119: Catalent Inc. - Overview
Exhibit 120: Catalent Inc. - Business segments
Exhibit 121: Catalent Inc. - Key news
Exhibit 122: Catalent Inc. - Key offerings
Exhibit 123: Catalent Inc. - Segment focus
12.7 Charles River Laboratories International Inc.
Exhibit 124: Charles River Laboratories International Inc. - Overview
Exhibit 125: Charles River Laboratories International Inc. - Business segments
Exhibit 126: Charles River Laboratories International Inc. - Key news
Exhibit 127: Charles River Laboratories International Inc. - Key offerings
Exhibit 128: Charles River Laboratories International Inc. - Segment focus
12.8 Cmic Holdings Co. Ltd.
Exhibit 129: Cmic Holdings Co. Ltd. - Overview
Exhibit 130: Cmic Holdings Co. Ltd. - Business segments
Exhibit 131: Cmic Holdings Co. Ltd. - Key offerings
Exhibit 132: Cmic Holdings Co. Ltd. - Segment focus
12.9 Dr Reddys Laboratories Ltd.
Exhibit 133: Dr Reddys Laboratories Ltd. - Overview
Exhibit 134: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 135: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 136: Dr Reddys Laboratories Ltd. - Segment focus
12.10 ICON plc
Exhibit 137: ICON plc - Overview
Exhibit 138: ICON plc - Product / Service
Exhibit 139: ICON plc - Key offerings
12.11 IQVIA Holdings Inc.
Exhibit 140: IQVIA Holdings Inc. - Overview
Exhibit 141: IQVIA Holdings Inc. - Business segments
Exhibit 142: IQVIA Holdings Inc. - Key news
Exhibit 143: IQVIA Holdings Inc. - Key offerings
Exhibit 144: IQVIA Holdings Inc. - Segment focus
12.12 Laboratory Corp. of America Holdings
Exhibit 145: Laboratory Corp. of America Holdings - Overview
Exhibit 146: Laboratory Corp. of America Holdings - Business segments
Exhibit 147: Laboratory Corp. of America Holdings - Key news
Exhibit 148: Laboratory Corp. of America Holdings - Key offerings
Exhibit 149: Laboratory Corp. of America Holdings - Segment focus
12.13 Lonza Group Ltd.
Exhibit 150: Lonza Group Ltd. - Overview
Exhibit 151: Lonza Group Ltd. - Business segments
Exhibit 152: Lonza Group Ltd. - Key news
Exhibit 153: Lonza Group Ltd. - Key offerings
Exhibit 154: Lonza Group Ltd. - Segment focus
12.14 Lupin Ltd.
Exhibit 155: Lupin Ltd. - Overview
Exhibit 156: Lupin Ltd. - Product / Service
Exhibit 157: Lupin Ltd. - Key news
Exhibit 158: Lupin Ltd. - Key offerings
12.15 Recipharm AB
Exhibit 159: Recipharm AB - Overview
Exhibit 160: Recipharm AB - Business segments
Exhibit 161: Recipharm AB - Key offerings
Exhibit 162: Recipharm AB - Segment focus
12.16 Samsung Electronics Co. Ltd.
Exhibit 163: Samsung Electronics Co. Ltd. - Overview
Exhibit 164: Samsung Electronics Co. Ltd. - Business segments
Exhibit 165: Samsung Electronics Co. Ltd. - Key news
Exhibit 166: Samsung Electronics Co. Ltd. - Key offerings
Exhibit 167: Samsung Electronics Co. Ltd. - Segment focus
12.17 Syneos Health Inc.
Exhibit 168: Syneos Health Inc. - Overview
Exhibit 169: Syneos Health Inc. - Business segments
Exhibit 170: Syneos Health Inc. - Key offerings
Exhibit 171: Syneos Health Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Service
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Service Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Service - Market share 2022-2027 (%)
Exhibits31: Data Table on Service - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Service
Exhibits33: Data Table on Comparison by Service
Exhibits34: Chart on CMO - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on CMO - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on CMO - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on CMO - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on CRO - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on CRO - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on CRO - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on CRO - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Service ($ billion)
Exhibits43: Chart on End-user - Market share 2022-2027 (%)
Exhibits44: Data Table on End-user - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by End-user
Exhibits46: Data Table on Comparison by End-user
Exhibits47: Chart on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits56: Data Table on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Chart on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by End-user ($ billion)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ billion)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Almac Group Ltd. - Overview
Exhibits109: Almac Group Ltd. - Product / Service
Exhibits110: Almac Group Ltd. - Key offerings
Exhibits111: Boehringer Ingelheim International GmbH - Overview
Exhibits112: Boehringer Ingelheim International GmbH - Business segments
Exhibits113: Boehringer Ingelheim International GmbH - Key news
Exhibits114: Boehringer Ingelheim International GmbH - Key offerings
Exhibits115: Boehringer Ingelheim International GmbH - Segment focus
Exhibits116: Cadila Pharmaceuticals Ltd. - Overview
Exhibits117: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits118: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits119: Catalent Inc. - Overview
Exhibits120: Catalent Inc. - Business segments
Exhibits121: Catalent Inc. - Key news
Exhibits122: Catalent Inc. - Key offerings
Exhibits123: Catalent Inc. - Segment focus
Exhibits124: Charles River Laboratories International Inc. - Overview
Exhibits125: Charles River Laboratories International Inc. - Business segments
Exhibits126: Charles River Laboratories International Inc. - Key news
Exhibits127: Charles River Laboratories International Inc. - Key offerings
Exhibits128: Charles River Laboratories International Inc. - Segment focus
Exhibits129: Cmic Holdings Co. Ltd. - Overview
Exhibits130: Cmic Holdings Co. Ltd. - Business segments
Exhibits131: Cmic Holdings Co. Ltd. - Key offerings
Exhibits132: Cmic Holdings Co. Ltd. - Segment focus
Exhibits133: Dr Reddys Laboratories Ltd. - Overview
Exhibits134: Dr Reddys Laboratories Ltd. - Business segments
Exhibits135: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits136: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits137: ICON plc - Overview
Exhibits138: ICON plc - Product / Service
Exhibits139: ICON plc - Key offerings
Exhibits140: IQVIA Holdings Inc. - Overview
Exhibits141: IQVIA Holdings Inc. - Business segments
Exhibits142: IQVIA Holdings Inc. - Key news
Exhibits143: IQVIA Holdings Inc. - Key offerings
Exhibits144: IQVIA Holdings Inc. - Segment focus
Exhibits145: Laboratory Corp. of America Holdings - Overview
Exhibits146: Laboratory Corp. of America Holdings - Business segments
Exhibits147: Laboratory Corp. of America Holdings - Key news
Exhibits148: Laboratory Corp. of America Holdings - Key offerings
Exhibits149: Laboratory Corp. of America Holdings - Segment focus
Exhibits150: Lonza Group Ltd. - Overview
Exhibits151: Lonza Group Ltd. - Business segments
Exhibits152: Lonza Group Ltd. - Key news
Exhibits153: Lonza Group Ltd. - Key offerings
Exhibits154: Lonza Group Ltd. - Segment focus
Exhibits155: Lupin Ltd. - Overview
Exhibits156: Lupin Ltd. - Product / Service
Exhibits157: Lupin Ltd. - Key news
Exhibits158: Lupin Ltd. - Key offerings
Exhibits159: Recipharm AB - Overview
Exhibits160: Recipharm AB - Business segments
Exhibits161: Recipharm AB - Key offerings
Exhibits162: Recipharm AB - Segment focus
Exhibits163: Samsung Electronics Co. Ltd. - Overview
Exhibits164: Samsung Electronics Co. Ltd. - Business segments
Exhibits165: Samsung Electronics Co. Ltd. - Key news
Exhibits166: Samsung Electronics Co. Ltd. - Key offerings
Exhibits167: Samsung Electronics Co. Ltd. - Segment focus
Exhibits168: Syneos Health Inc. - Overview
Exhibits169: Syneos Health Inc. - Business segments
Exhibits170: Syneos Health Inc. - Key offerings
Exhibits171: Syneos Health Inc. - Segment focus
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations

この商品のレポートナンバー

0000033965

TOP